vegfr1-a24-1084
Vaccineexperimental
Clinical trial activity
2 trials · 3 clinical orgs · 0 marketing orgs
Phase 1
2
Phase 2
2
Phase 3
0
Phase 4
0
Earliest trial started Jul 1, 2003 (NCT00089219)
Timeline
2000s
- Jan 1, 2003
Earliest Phase 1 Sponsor(trial)
Indications
Mechanism of action
- Vascular endothelial growth factor receptor 1Immunity, active
FLT1 immunity, active
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Also known as
- ifa
- vegfr1-a24-1084
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT00683358 | Phase 1/Phase 2 (Phase 2) | May 1, 2008 | University of Tokyo |
| NCT00089219 | Phase 1/Phase 2 (Phase 2) | Jul 1, 2003 | National Cancer Institute (NCI), University of Virginia |
Showing 2 of 2 trials
Page 1 / 1
Organizations
Research & Development (3)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| National Cancer Institute (NCI) | Government | 1 | 0 | 1 | 2003 |
| University of Tokyo | Academic/Hospital | 1 | 1 | 1 | 2008 |
| University of Virginia | Academic/Hospital | 1 | 1 | 1 | 2003 |
3 organizations
Page 1 / 1